Brehm Merel-Anne, Verduijn Suzan, Bon Jurgen, Bredt Nicoline, Nollet Frans
Department of Rehabilitation , Academic Medical Center, University of Amsterdam, PO 22660, 1100 DD Amsterdam, The Netherlands.
J Rehabil Med. 2017 Nov 21;49(9):732-737. doi: 10.2340/16501977-2264.
To compare walking dynamics and test-retest reliability for 2 frequently applied walk tests in polio survivors: the 6-minute walk test (6MWT) to walk as far as possible; and the 6-minute walking energy cost test (WECT) at comfortable speed.
Observational study.
Thirty-three polio survivors, able to walk ≥ 150 m.
On the same day participants performed a 6MWT and a WECT, which were repeated 1-3 weeks later. For each test, distance walked, heart rate and reduction in speed were assessed.
The mean distance walked and mean heart rate were significantly higher in the 6MWT (441 m (standard deviation) (SD 79.7); 118 bpm (SD 19.2)) compared with the WECT (366 m (SD 67.3); 103 bpm (SD 14.3)); p< 0.001. Furthermore, during the 6MWT, patients continuously slowed down (-6%), while during the WECT speed dropped only slightly during the first 2 min, by -1.8% in total. Test-retest reliability of both tests was excellent (intraclass correlation coefficient (ICC) ≥ 0.95; lower bound 95% confidence interval (95% CI) ≥ 0.87). The smallest detectable change for the walked distance was 42 m (9.7% change from the mean) and 50 m (13.7%) on the 6MWT and WECT, respectively.
Both the 6MWT and the WECT are reliable to assess walking capacity in polio survivors, with slightly superior sensitivity to detect change for the 6MWT. Differences in walking dynamics confirm that the tests cannot be used interchangeably. The 6MWT is recommended for measuring maximal walking capacity and the WECT for measuring submaximal walking capacity.
比较脊髓灰质炎幸存者中两种常用步行测试的步行动力学和重测信度:6分钟步行测试(6MWT),即尽可能远距离行走;以及以舒适速度进行的6分钟步行能量消耗测试(WECT)。
观察性研究。
33名能够行走≥150米的脊髓灰质炎幸存者。
参与者在同一天进行6MWT和WECT测试,并在1至3周后重复测试。对于每项测试,评估行走距离、心率和速度降低情况。
与WECT(366米(标准差[SD]67.3);103次/分钟(SD 14.3))相比,6MWT的平均行走距离和平均心率显著更高(441米(SD 79.7);118次/分钟(SD 19.2));p<0.001。此外,在6MWT期间,患者持续减速(-6%),而在WECT期间,速度仅在前2分钟略有下降,总共下降-1.8%。两项测试的重测信度均极佳(组内相关系数[ICC]≥0.95;下限95%置信区间[95%CI]≥0.87)。6MWT和WECT行走距离的最小可检测变化分别为42米(相对于平均值变化9.7%)和50米(13.7%)。
6MWT和WECT在评估脊髓灰质炎幸存者的步行能力方面均可靠,6MWT检测变化的敏感性略高。步行动力学的差异证实这两项测试不能互换使用。建议使用6MWT测量最大步行能力,使用WECT测量次最大步行能力。